HSPA5 and atherosclerosis: These preliminary data suggest potential utility in the use of belimumab as a treatment for atherosclerosis, but there is a clear need for longer follow-up data to investigate whether this reduction in anti-GRP78 translates into a reduction in cardiovascular events.